17400-77-0; p-Nitrophenyl-alpha-D-maltoside; 4-NITROPHENYL 4-O-ALPHA-D-GLUCOPYRANOSYL-ALPHA-D-GALACTOPYRANOSIDE; (2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; 4-nitrophenyl 4-o-; A-d-glucopyranosyl-; A-d-glucopyranoside; 4-Nitrophenyl a-D-maltopyranoside; (2R,3R,4S,5S,6R)-2-(((2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; 4-Nitrophenylmaltoside; para-Nitrophenylmaltoside; P-NITROPHENYL MALTOSIDE; 4-Nitrophenyl-alpha-D-maltopyranoside; 2ggx; PNP-alpha-D-maltoside; 4-Nitrophenyl alpha-D-maltoside; SCHEMBL14359612; DTXSID60938456; ZINC4282193; MFCD00036769; p-Nitrophenyl- alpha -D-Laminaribioside; 4-Nitrophenyl- alpha -D-maltopyranoside; NPJ; 4-Nitrophenyl 4-O-hexopyranosylhexopyranoside; S11468; 4-Nitrophenyl alpha-D-maltoside, glycosidase substrate; Q27463901; a-D-Glucopyranoside,4-nitrophenyl4-O-a-D-glucopyranosyl-; alpha-D-Glucopyranoside, 4-nitrophenyl 4-O-alpha-D-glucopyranosyl-; (2R,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-DIHYDROXY-2-(HYDROXYMETHYL)-6-(4-NITROPHENOXY)OXAN-3-YL]OXY}-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL